HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Robert L. Kormos William R. Wagner Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wilhelm, C. R. Articles by Wagner, W. R. Search for Related Content PubMed PubMed Citation Articles by Wilhelm, C. R. Articles by Wagner, W. R.

Ann Thorac Surg 1998;65:1071-1076
© 1998 The Society of Thoracic Surgeons

Monocyte Tissue Factor Expression and Ongoing Complement Generation in Ventricular Assist Device Patients

^a Department of Surgery and Artificial Heart Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

Accepted for publication November 23, 1997.

Address reprint requests to Dr Wagner, Department of Surgery, University of Pittsburgh Medical Center, 328 Scaife Hall, 200 Lothrop St, Pittsburgh, PA 15213
e-mail: (wagner{at}pittsurg.nb.upmc.edu)

Background. Ongoing complement activation in patients with a ventricular assist device may contribute to observed hemostatic abnormalities and cellular aggregation by mediating leukocyte and platelet activation, formation of leukocyte-platelet conjugates, and the tissue factor pathway of coagulation.

Methods. Blood from 30 patients was collected before ventricular assist device implantation and during the implantation period. Plasma levels of thrombin–antithrombin III complexes, C3a, and SC5b-9 were measured by commercial enzyme-linked immunosorbent assay. Flow cytometry was used to measure circulating monocyte tissue factor expression and circulating monocyte–platelet and granulocyte–platelet conjugates.

Results. Thrombin–antithrombin III complex level and monocyte tissue factor expression peaked in the early postoperative period, with maxima occurring on postoperative days 5 and 3, respectively. Levels of C3a and SC5b-9 remained dramatically elevated over normal values for the duration of the study (6 and 5 times upper normal, respectively). Levels of monocyte–platelet conjugates were normal before implantation, decreased during the first 4 postoperative days, and then increased and remained elevated. Levels of granulocyte–platelet conjugates were elevated over the normal range before implantation and remained elevated from postoperative days 3 to 21. A positive correlation was found between levels of SC5b-9 and granulocyte–platelet conjugates (Spearman R = 0.66; p < 0.001), and between levels of C3a and thrombin–antithrombin III complex (Spearman R = 0.13; p = 0.021).

Conclusions. The data suggest a model in which complement mediates formation of leukocyte–platelet aggregates and may indirectly contribute to thrombin generation through monocyte tissue factor expression.

This article has been cited by other articles:

				P. Redecha, R. Tilley, M. Tencati, J. E. Salmon, D. Kirchhofer, N. Mackman, and G. Girardi Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury Blood, October 1, 2007; 110(7): 2423 - 2431. [Abstract] [Full Text] [PDF]

				R. Houel, E. Mazoyer, B. Boval, M. Kirsch, E. Vermes, L. Drouet, and D. Y. Loisance Platelet activation and aggregation profile in prolonged external ventricular support J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 197 - 202. [Abstract] [Full Text] [PDF]

				C. R. Wilhelm, J. Ristich, L. E. Knepper, R. Holubkov, S. R. Wisniewski, R. L. Kormos, and W. R. Wagner Measurement of Hemostatic Indexes in Conjunction With Transcranial Doppler Sonography in Patients With Ventricular Assist Devices Stroke, December 1, 1999; 30(12): 2554 - 2561. [Abstract] [Full Text] [PDF]